Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02331251
Title Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Western Regional Medical Center
Indications

lung small cell carcinoma

pancreatic adenocarcinoma

sarcoma

Advanced Solid Tumor

Therapies

Vinorelbine

Pembrolizumab

Irinotecan

Doxorubicin

Gemcitabine

Docetaxel

Nab-paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.